newsfilter
← Latest News
Business Wire·

Viridian Therapeutics to Participate in Upcoming June Investor Conferences

Viridian Therapeutics, Inc. (NASDAQ:VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that